Maximus, Inc. (NYSE:MMS) Shares Sold by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. trimmed its position in Maximus, Inc. (NYSE:MMS) by 4.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 30,591 shares of the health services provider’s stock after selling 1,560 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Maximus were worth $2,284,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. V Square Quantitative Management LLC acquired a new stake in shares of Maximus in the third quarter valued at $25,000. UMB Bank n.a. raised its position in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after acquiring an additional 158 shares in the last quarter. Eastern Bank acquired a new stake in Maximus in the 4th quarter valued at about $29,000. R Squared Ltd bought a new position in shares of Maximus during the 4th quarter valued at about $54,000. Finally, GAMMA Investing LLC raised its holdings in shares of Maximus by 150.6% in the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock worth $80,000 after purchasing an additional 518 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Insider Activity

In other Maximus news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the sale, the insider now directly owns 6,567 shares in the company, valued at approximately $484,841.61. This trade represents a 25.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Bruce Caswell bought 3,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The stock was acquired at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the acquisition, the chief executive officer now directly owns 275,929 shares in the company, valued at $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 7,063 shares of company stock worth $502,017. 1.60% of the stock is owned by corporate insiders.

Maximus Trading Down 7.3 %

Shares of MMS opened at $70.29 on Friday. The business’s 50-day moving average price is $74.83 and its 200 day moving average price is $83.53. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $4.01 billion, a P/E ratio of 14.06 and a beta of 0.72. Maximus, Inc. has a 1-year low of $69.72 and a 1-year high of $93.97.

Maximus (NYSE:MMS) last released its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.78% and a return on equity of 20.95%. Analysts expect that Maximus, Inc. will post 5.95 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.71%. Maximus’s dividend payout ratio (DPR) is presently 24.00%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on MMS shares. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a report on Thursday.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.